BioNexus Gene Lab Corp
BGLC- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001737523
No open-market purchases or sales by BioNexus Gene Lab Corp insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $27.2K in total; no superinvestor holds it.
Holders of 5% or more of BGLC
Holders whose latest Schedule 13D or 13G filing reports 5% or more of BioNexus Gene Lab Corp, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of BioNexus Gene Lab Corp on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on BioNexus Gene Lab Corp, newest first.
No Schedule 13D or 13G filings on BioNexus Gene Lab Corp are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell BioNexus Gene Lab Corp shares.
No Form 144 notices for BioNexus Gene Lab Corp are on file.